Genome BC is pleased to announce a further investment of $500,000 in addition to $1 million last year to LightIntegra Technology (LIT). LIT has developed the first analyzer to provide a routine test for platelet activation status. A Vancouver based medical device company, LIT is focused on improving the quality of and providing the necessary level of blood platelets in…
Read More
Universities are not the only public institutions where highly educated scientists can pursue a fruitful career — these specific skills, abilities, and knowledge are also direly needed in government positions to develop and introduce policies. Does that sound like the way you would like to make a difference? We wanted to learn more about scientific careers in government agencies, thus,…
Read More
A B.C. biotech firm developing a one-minute COVID-19 test has just landed federal funding worth $633,000. Richmond-based bioLytical Laboratories Inc. is perhaps best known for its INSTI HIV test, which delivers results within 60 seconds. The company is now in the midst of porting that expertise into the realm of COVID-19 with funding from the National Research Council of Canada Industrial…
Read More
The Canadian arm of a major international clinical trial—led by a University of British Columbia researcher—that aims to find the best treatment for COVID-19 has received an additional $3.5 million in funding from the federal government through the Canadian Institutes of Health Research (CIHR). The Canadian Treatments for COVID-19 (CATCO) trial is the Canadian arm of the World Health Organization’s…
Read More

May 2020 Award Winners

Dr. Anna McGuire has received a Vancouver Coastal Health Research Institute Award for her study into the utility of blood “liquid biopsy” for lung cancer circulating tumour DNA in surgical patients. Find out which other Vancouver researchers won grants, awards and scholarships in our May 2020 award summary!
Read More
In March the world seemingly stopped. Plans were cancelled, some of our favourite places closed, and we all learned how to estimate two metres of distance. But while all this stopping and staying home happened, all across our communities, people were stepping up. Medical experts at Vancouver General Hospital (VGH) and other health care centres across the province swiftly pivoted…
Read More
Productivity, drive, and a penchant for cutting-edge technologies have characterized the career of LSI’s Dr. Don Moerman, Professor Emeritus in the Dept. of Zoology. We spoke to him about his focus on Caenorhabditis elegans biology and functional genomics, and what it took to engineer the success of the C. elegans Knockout Project, an international consortium created to generate knockouts in every one of the…
Read More
Genome BC is pleased to announce $1 million in funding to Sonic Incytes Medical Corp., completing the company’s seed financing round of over CDN$3.5 million supported by institutional investors, angel funds and private individuals. Vancouver based Sonic Incytes is developing a breakthrough, point of care ultrasound solution for assessing and managing chronic liver disease – an emerging global health crisis,…
Read More

People in Profile: Jack Bacon

Meet Jack—Speaking up and spreading the word about cancer research. Q: What is your role in health research? A: I am a PhD student working with principal investigator Dr. Alex Wyatt at the Vancouver Prostate Centre (VPC). Q: What is your research area of interest, and what led you to that interest? A: Broadly, I study the genomics of genitourinary cancer, including…
Read More

How B.C. Scientists are Addressing the COVID-19 Testing Challenge

As the COVID-19 pandemic continues, public health authorities around the world are facing a significant challenge: ensuring a large enough supply of reagents to scale-up diagnostic testing. Researchers at Canada’s Michael Smith Genome Sciences Centre at BC Cancer (GSC), the University of British Columbia (UBC) and the BC Centre for Disease Control (BCCDC) are working to develop new non-proprietary reagents…
Read More